LBA92Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19)

S A Burgers,C de Gooijer,R Cornelissen,J G Aerts,B Biesma, R V Heemst,M Youssef-El Soud,H J M Groen, A J Staal-van den Brekel,G Bootsma, J H E M Schijen,P Baas,E Giovannetti,J F de Vries, F A Hogenboom, D C M de Wit, M C W Mahn Schaefers, F Lalezari, V van de Noort,J Stigt

ANNALS OF ONCOLOGY(2019)

引用 6|浏览29
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要